“Leaders of Tomorrow” gathers young people from Israel and Morocco to develop social entrepreneurial projects that will serve both countries
Expo showcased Israeli companies that are leading the way toward smart mobility
Oramed says it is months away from completing a Phase III clinical trial on what it hopes will become the world’s first oral insulin treatment for type 2 diabetics
Maayan Hoffman is a veteran American-Israeli journalist and strategic communications consultant. She is Deputy CEO - Strategy & Innovation for the Jerusalem Post, where she also served as news editor, head of strategy and senior health analyst.